The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)April 1, 2026 — Rail Vision (NASDAQ: RVSN) reported financial results for the second half and full year ended Dec. 31, 2025, citing revenue growth and continued operational progress as it expands its global footprint.
April 1, 2026 — Safe Pro Group (NASDAQ: SPAI) announced it has received a contract modification to provide continued support for its AI Edge Processing solution under an existing subcontract with the U. S.
April 1, 2026 — LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2025, outlining a year marked by leadership changes, clinical progress and strategic expansion.
April 1, 2026 — Datavault AI (NASDAQ: DVLT) CEO Nate Bradley will present at a private investor roundtable on April 2, 2026, at The Mar-a-Lago Club in Palm Beach, Florida, marking his second invitation in two months amid growing institutional interest in the company’s data monetization, tokenization and AI-driven platform. The event builds on momentum from a February engagement where Datavault AI highlighted $49 million in fourth-quarter 2025 agreements and projected more than $30 million in fiscal 2025 revenue, as the company continues to position itself at the intersection of data ownership, verified credentialing and real-world asset tokenization.
April 1, 2026 — This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.
April 1, 2026 — Beeline Holdings Inc. , in a recent update call, reported 127% year-over-year revenue growth for Q4 2025, reflecting the expansion of its digital mortgage platform.
March 31, 2026 — The United States Army has introduced new recruitment rules that expand eligibility, allowing older applicants to join. Under the updated policy, individuals up to 42 years old can now enlist in active duty, the Army Reserve, and the Army National Guard.
March 31, 2026 — Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently finished its first full reporting period as the world’s largest Solana treasury. A recent article shares details from an announcement of the company’s fiscal first quarter 2026 operating and financial results, updates, milestones and future plans.
March 31, 2026 — HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed Joseph Gunnar & Co. ’s upgrade of the company from Hold to Buy and raising of its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization.
March 31, 2026 — Frontieras North America will host a groundbreaking ceremony on Thursday, April 2, 2026, at 11:30 a. m.
March 31, 2026 — U. S.
March 31, 2026 — LIXTE’s lead compound, LB-100, is the world’s first and only clinical-stage inhibitor of protein phosphatase 2A (“PP2A”). LB-100 helps in the fight against cancer in a few ways, as it makes cancer cells more sensitive to immunotherapy and chemotherapy, while also disrupting cancer’s internal repair system.
March 31, 2026 — Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.
March 31, 2026 — Datavault AI (NASDAQ: DVLT) announced the closing of a definitive agreement with Coppercore Inc. to digitize and tokenize copper resources through its proprietary blockchain platform, targeting the creation of $100 million or more in Coppercoin(TM) digital tokens.
March 31, 2026 — Ucore Rare Metals (TSX. V: UCU) (OTCQX: UURAF) acknowledged its partner Hastings Technology Metals, alongside Wyloo, for acquiring a fully permitted mixed rare earth chloride production facility in Thailand, a move expected to accelerate near-term processing of monazite feedstock and strengthen a Western-aligned rare earth supply chain.
March 31, 2026 — Telomir Pharmaceuticals (NASDAQ: TELO) announced the submission of an Investigational New Drug application to the FDA for Telomir-1 (Telomir-Zn) targeting advanced and metastatic triple-negative breast cancer, supported by preclinical efficacy and safety data demonstrating tumor growth reduction and favorable tolerability. Pending IND clearance, the company plans to initiate a Phase 1/2 clinical trial evaluating the oral therapy, with a focus on safety, dose optimization and early signs of antitumor activity, as it advances a novel epigenetic approach aimed at addressing significant unmet need in aggressive breast cancer.
March 31, 2026 — Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.
March 31, 2026 — Surging oil prices are reshaping buying decisions for millions of drivers, and Chinese electric vehicle manufacturers are positioned to benefit the most. Geopolitical instability across the Middle East has pushed crude oil to above $100 per barrel, unsettling fuel markets worldwide.
March 31, 2026 — A team of scientists from Texas Children’s Hospital, University of Pittsburgh and Baylor College of Medicine has discovered the primary driver of a deadly pediatric brain cancer, PFA (posterior fossa type A) ependymoma. They identified male sex hormones called androgens as playing a key role in promoting PFA ependymoma growth.
March 31, 2026 — Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.